Diamond Biofund Inc. (TPE:6901)
18.35
-0.75 (-3.93%)
Jul 17, 2026, 1:30 PM CST
Diamond Biofund Revenue
Diamond Biofund had revenue of -336.28M TWD in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to -863.18M. In the year 2025, Diamond Biofund had annual revenue of -1.07B.
Revenue (ttm)
-863.18M
Revenue Growth
n/a
P/S Ratio
-18.87
Revenue / Employee
-29.76M
Employees
29
Market Cap
16.29B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | -1.07B | 1.16B | - |
| Dec 31, 2024 | -2.23B | 210.73M | - |
| Dec 31, 2023 | -2.44B | -3.46B | - |
| Dec 31, 2022 | 1.02B | -2.05B | -66.85% |
| Dec 31, 2021 | 3.06B | -3.44B | -52.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Cathay Financial Holding | 1.19T |
| Fubon Financial Holding | 1.05T |
| CTBC Financial Holding | 583.29B |
| Mercuries & Associates Holding | 159.30B |
| TS Financial Holding | 129.67B |
| Farglory Life Insurance | 90.50B |
| China Man-Made Fiber | 43.92B |
| Taiwan Fire & Marine Insurance | 7.39B |